EUVIMEDEUVIMED entdecken
Open Access

Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race

Jennifer K Frediani, Ezra Pak-Harvey, Richard Parsons, Adrianna L Westbrook, William O'Sick, Greg S Martin, Wilbur A Lam, Joshua M Levy

Blood Cells, Molecules, and Diseases · 2023

DOI: 10.1016/j.bcmd.2023.102756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2023. Verfasst von Jennifer K Frediani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologie…. Hauptthemen laut MEDLINE: COVID-19, Hemoglobinopathies, Anemia, Sickle Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prior literature has established a positive association between sickle cell disease and risk of contracting SARS-CoV-2. Data from a cross-sectional study evaluating COVID-19 testing devices (n = 10,567) was used to examine the association between underlying health conditions and SARS-CoV-2 infection in an urban metropolis in the southern United States. Firth's logistic regression was used to fit the model predicting SARS-CoV-2 positivity using vaccine status and different medical conditions commonly associated with COVID-19. Another model using the same method was built using SARS-CoV-2 positivity as the outcome and hemoglobinopathy presence, age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HemoglobinopathiesAnemia, Sickle CellHumansUnited StatesAdolescentSARS-CoV-2COVID-19 TestingPrevalenceCross-Sectional Studies

Stichwörter der Autor:innen

COVID-19HemoglobinopathyPrevalenceSARS-CoV-2Sickle cell disease

Autor:innen und Institutionen

  • Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA; The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine,Atlanta, GA, USA.
  • The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, USA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Emory/Children's Laboratory for Innovative Assay Development, Atlanta, GA, USA.
  • Department of Pulmonology, Emory University School of Medicine, Atlanta, GA, USA.
  • The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School…

Förderung

  • NIBIB NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Frediani, J. K., Pak-Harvey, E., Parsons, R., Westbrook, A. L., O'Sick, W., Martin, G. S., Lam, W. A., & Levy, J. M. (2023). Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2023.102756

Vancouver

Frediani JK, Pak-Harvey E, Parsons R, Westbrook AL, O'Sick W, Martin GS, et al. Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race. Blood Cells, Molecules, and Diseases. 2023. doi:10.1016/j.bcmd.2023.102756

BibTeX
@article{Frediani2023,
  author = {Frediani, Jennifer K and Pak-Harvey, Ezra and Parsons, Richard and Westbrook, Adrianna L and O'Sick, William and Martin, Greg S and Lam, Wilbur A and Levy, Joshua M},
  title = {Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2023},
  doi = {10.1016/j.bcmd.2023.102756}
}
Kostenlos starten →